Cargando…
Identification and characterization of novel mutations implicated in congenital fibrinogen disorders
ESSENTIALS: Fibrinogen Disorders are characterized by variable expressivity. Patients with fibrinogen disorders can present with bleeding, thrombosis, or both. As previously reported, genotype‐phenotype correlations are difficult to establish. Molecular modeling may help to further understand the ef...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178649/ https://www.ncbi.nlm.nih.gov/pubmed/30349899 http://dx.doi.org/10.1002/rth2.12127 |
_version_ | 1783361978032455680 |
---|---|
author | Smith, Natalie Bornikova, Larissa Noetzli, Leila Guglielmone, Hugo Minoldo, Salvador Backos, Donald S. Jacobson, Linda Thornburg, Courtney D. Escobar, Miguel White‐Adams, Tara C. Wolberg, Alisa S. Manco‐Johnson, Marilyn Di Paola, Jorge |
author_facet | Smith, Natalie Bornikova, Larissa Noetzli, Leila Guglielmone, Hugo Minoldo, Salvador Backos, Donald S. Jacobson, Linda Thornburg, Courtney D. Escobar, Miguel White‐Adams, Tara C. Wolberg, Alisa S. Manco‐Johnson, Marilyn Di Paola, Jorge |
author_sort | Smith, Natalie |
collection | PubMed |
description | ESSENTIALS: Fibrinogen Disorders are characterized by variable expressivity. Patients with fibrinogen disorders can present with bleeding, thrombosis, or both. As previously reported, genotype‐phenotype correlations are difficult to establish. Molecular modeling may help to further understand the effects of mutations on the mature fibrinogen protein. INTRODUCTION: Fibrinogen is a complex molecule comprised of two sets of Aα, Bβ, and γ chains. Fibrinogen deficiencies can lead to the development of bleeding or thromboembolic events. The objective of this study was to perform DNA sequence analysis of patients with clinical fibrinogen abnormalities, and to perform genotype‐phenotype correlations. MATERIALS AND METHODS: DNA from 31 patients was sequenced to evaluate disease‐causing mutations in the three fibrinogen genes: FGA,FGB, and FGG. Clinical data were extracted from medical records or from consultation with referring hematologists. Fibrinogen antigen and functional (Clauss method) assays, as well as reptilase time (RT) and thrombin time (TT) were obtained for each patient. Molecular modeling was used to simulate the functional impact of specific missense variants on the overall protein structure. RESULTS: Seventeen mutations, including six novel mutations, were identified in the three fibrinogen genes. There was little correlation between genotype and phenotype. Molecular modeling predicted a substantial conformational change for a novel variant, FGG p.Ala289Asp, leading to a more rigid molecule in a region critical for polymerization and alignment of the fibrin monomers. This mutation is associated with both bleeding and clotting in the two affected individuals. CONCLUSIONS: Robust genotype‐phenotype correlations are difficult to establish for fibrinogen disorders. Molecular modeling might represent a valuable tool for understanding the function of certain missense fibrinogen mutations but those should be followed by functional studies. It is likely that genetic and environmental modifiers account for the incomplete penetrance and variable expressivity that characterize fibrinogen disorders. |
format | Online Article Text |
id | pubmed-6178649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61786492018-10-22 Identification and characterization of novel mutations implicated in congenital fibrinogen disorders Smith, Natalie Bornikova, Larissa Noetzli, Leila Guglielmone, Hugo Minoldo, Salvador Backos, Donald S. Jacobson, Linda Thornburg, Courtney D. Escobar, Miguel White‐Adams, Tara C. Wolberg, Alisa S. Manco‐Johnson, Marilyn Di Paola, Jorge Res Pract Thromb Haemost Original Articles: Haemostasis ESSENTIALS: Fibrinogen Disorders are characterized by variable expressivity. Patients with fibrinogen disorders can present with bleeding, thrombosis, or both. As previously reported, genotype‐phenotype correlations are difficult to establish. Molecular modeling may help to further understand the effects of mutations on the mature fibrinogen protein. INTRODUCTION: Fibrinogen is a complex molecule comprised of two sets of Aα, Bβ, and γ chains. Fibrinogen deficiencies can lead to the development of bleeding or thromboembolic events. The objective of this study was to perform DNA sequence analysis of patients with clinical fibrinogen abnormalities, and to perform genotype‐phenotype correlations. MATERIALS AND METHODS: DNA from 31 patients was sequenced to evaluate disease‐causing mutations in the three fibrinogen genes: FGA,FGB, and FGG. Clinical data were extracted from medical records or from consultation with referring hematologists. Fibrinogen antigen and functional (Clauss method) assays, as well as reptilase time (RT) and thrombin time (TT) were obtained for each patient. Molecular modeling was used to simulate the functional impact of specific missense variants on the overall protein structure. RESULTS: Seventeen mutations, including six novel mutations, were identified in the three fibrinogen genes. There was little correlation between genotype and phenotype. Molecular modeling predicted a substantial conformational change for a novel variant, FGG p.Ala289Asp, leading to a more rigid molecule in a region critical for polymerization and alignment of the fibrin monomers. This mutation is associated with both bleeding and clotting in the two affected individuals. CONCLUSIONS: Robust genotype‐phenotype correlations are difficult to establish for fibrinogen disorders. Molecular modeling might represent a valuable tool for understanding the function of certain missense fibrinogen mutations but those should be followed by functional studies. It is likely that genetic and environmental modifiers account for the incomplete penetrance and variable expressivity that characterize fibrinogen disorders. John Wiley and Sons Inc. 2018-07-02 /pmc/articles/PMC6178649/ /pubmed/30349899 http://dx.doi.org/10.1002/rth2.12127 Text en © 2018 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals, Inc on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles: Haemostasis Smith, Natalie Bornikova, Larissa Noetzli, Leila Guglielmone, Hugo Minoldo, Salvador Backos, Donald S. Jacobson, Linda Thornburg, Courtney D. Escobar, Miguel White‐Adams, Tara C. Wolberg, Alisa S. Manco‐Johnson, Marilyn Di Paola, Jorge Identification and characterization of novel mutations implicated in congenital fibrinogen disorders |
title | Identification and characterization of novel mutations implicated in congenital fibrinogen disorders |
title_full | Identification and characterization of novel mutations implicated in congenital fibrinogen disorders |
title_fullStr | Identification and characterization of novel mutations implicated in congenital fibrinogen disorders |
title_full_unstemmed | Identification and characterization of novel mutations implicated in congenital fibrinogen disorders |
title_short | Identification and characterization of novel mutations implicated in congenital fibrinogen disorders |
title_sort | identification and characterization of novel mutations implicated in congenital fibrinogen disorders |
topic | Original Articles: Haemostasis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178649/ https://www.ncbi.nlm.nih.gov/pubmed/30349899 http://dx.doi.org/10.1002/rth2.12127 |
work_keys_str_mv | AT smithnatalie identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders AT bornikovalarissa identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders AT noetzlileila identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders AT guglielmonehugo identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders AT minoldosalvador identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders AT backosdonalds identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders AT jacobsonlinda identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders AT thornburgcourtneyd identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders AT escobarmiguel identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders AT whiteadamstarac identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders AT wolbergalisas identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders AT mancojohnsonmarilyn identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders AT dipaolajorge identificationandcharacterizationofnovelmutationsimplicatedincongenitalfibrinogendisorders |